Hepatitis B vaccination in women healthcare workers: A seroepidemiological survey

European Journal of Epidemiology

Volumn 22, Issue 2, 2007, Pages 113-119

  Locquet, C ^a   Marande, J L ^b   Choudat, D ^b   Vidal Trecan, G ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Service de Médecine du Travail ^*  (France)

Author keywords

Anti HBs antibody; Healthcare workers; Hepatitis B vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; FRANCE; GENERAL HOSPITAL; HEALTH CARE PERSONNEL; HEALTH HAZARD; HEALTH SURVEY; HEPATITIS B; HUMAN; LONGITUDINAL STUDY; NORMAL HUMAN; OCCUPATIONAL HEALTH; RETROSPECTIVE STUDY; SERODIAGNOSIS; SOCIAL STATUS; UNIVERSITY HOSPITAL; VACCINATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; LONGITUDINAL STUDIES; PERSONNEL, HOSPITAL; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 33947368189     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9094-x     Document Type: Article

References (34)

1. Pepe PE, Hollinger FB, Troisi CL, Heiberg D. Viral hepatitis risk in urban emergency medical services personnel. Ann Emerg Med 1986; 15: 454-457.
2. Scheiermann N, Kuwert EK, Pieringer E, Dermietzel R. High-risk groups for hepatitis B virus infection in a university hospital staff as determined by detection of HB antigens, antibodies, and Dane particles. Med Microbiol Immunol 1978; 166: 241-247.
3. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13(Suppl 1): S47-S49.
4. Abiteboul D, Forestier-Auter AF, Domart M, Laville MF, Touche S, Bouvet E, Leprince A, Conso F. Les accidents avec exposition au sang. Concours Med 2000; 122: 539-345.
5. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997; 157: 2601-2605.
6. Treadwell TL, Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, Howell CD, deMedina M, Schiff ER, Jensen DM, Koff RS. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med 1993; 6: 584-588.
7. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Clin Liver Dis 2004; 8: 283-300.
8. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993; 270: 2931-2934.
9. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998; 15: 1-8.
10. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccine. Infect Dis Clin North Am 2006; 20: 27-45.
11. Alimonos K, Nafziger AN, Murray J, Bertino JS Jr. Prediction of response to hepatits B vaccine in health care workers:whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness?. Clin Infect Dis 1998; 26: 566-571.
12. Bronowicki JP, Weber-Larivaille F, Gut JP, Doffoel M, Vetter D. Comparison of immunogenicity of vaccination and serovaccination against hepatitis B virus in patients with alcoholic cirrhosis. Gastroenterol Clin Biol 1997; 21: 848-853.
13. Fleming SJ, Moran DM, Cooksley WG, Faoagali, JL. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991; 22: 251-257.
14. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: Multiple HLA genes are involved. Tissue Antigens 1998; 51: 593-604.
15. Leroux-Roels G, Abraham B, Fourneau M, De Clercq N, Safary A. A comparison of two commercial recombinant vaccines for hepatitis B in adolescents. Vaccine 2000; 19: 937-942.
16. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005; 23: 2902-2908.
17. Playford EG, Hogan PG, Bansal AS, Harrison K, Drummond D, Looke DF, Whitby M. Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol 2002; 23: 87-90.
18. Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dicson B, Young MD. Hepacare Study Group. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 2001; 34: 798-802.
19. van der Sande MA , Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ Jeffries D, Hall AJ, Whittle HC. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193: 1528-1535.
20. Ballinger AB, Clark ML. Severe acute hepatitis B infection after vaccination. Lancet 1994; 344: 1292.
21. Goffin E, Horsmans Y, Cornu C, Geubel A, Pirson Y. Acute hepatitis B infection after vaccination. Lancet 1995; 345: 263.
22. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen:implications for policy on booster vaccination. Vaccine 1996; 14: 1019-1027.
23. European consensus group on hepatitis B immunity. Are booster immunisations needed for hepatitis B immunity? Lancet 2000; 355: 561-565.
24. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R. Long-term persistence of anti-HBs after vaccination against HBV: An 18-year experience in health care workers. Vaccine 2004; 22: 607-610.
25. Boxall EH, Sira JA, El-Shuhkri N, Kelly DA. Long term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004; 190: 1264-1269.
26. Durlach R, Laugas S, Freuler CB, Rodriguez VE, Costa M. Ten-year persistence of antibody to hepatitis B surface antigen in healthcare workers vaccinated against hepatitis B virus, and response to booster vaccination. Infect Control Hosp Epidemiol 2003; 24: 773-776.
27. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis. Clin Infect Dis 2002; 35: 1368-1375.
28. Williams JL, Christensen CJ, Mc Mahon BJ, Bulkow LR, Cagle HH, Mayers JS, Zanis CL, Parkinson AJ, Margolis HS. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine 2001; 19: 4081-4085.
29. Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two and three dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics 2001; 107: 626-631.
30. Richardson D, Wing S, Steenland K, McKelvey W. Time-related aspects of the healthy worker survivor effect. Ann Epidemiol 2004; 14: 633-639.
31. Goldwater PN. Randomized, comparative trial of 20 μg versus 40 μg Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997; 15: 353-356.
32. Cardell K, Fryden A, Normann B. Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise. Scand J Infect Dis 1999; 31: 197-200.
33. Zuckerman JN, Zuckerman AJ. Recombinant hepatitis B triple antigen vaccine:Hepacare. Expert Rev Vaccines 2002; 1: 141-144.
34. Jahnz-Rozyk K, Brydak LB, Targowski T, Machala M, Plusa T. Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma. Mediators Inflamm 2004; 13: 195-199.